Concepedia

Mitch Brinkkemper

MB

Statistics

Publications

14

Citations

585

H-Index

13

Active since

2018

Affiliations

University of Amsterdam(Current)

Amsterdam University Medical Centers

Scripps Research Institute

Cornell University

Amsterdam Neuroscience

Mitch Brinkkemper is an author at University of Amsterdam specializing in immunology, infectious diseases, and sars-cov-2 infection.

ORCID

Publications per year

2018–2024

14

Publications

14

Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse et al. · Cell · 2021 · 205 citations · Full text

, , +17

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

Mathieu Claireaux, Tom G. Caniels, Marlon de Gast et al. · Nature Communications · 2022 · 72 citations · Full text

, , +17

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

Pauline Maisonnasse, Yoann Aldon, Aurélien Marc et al. · Nature Communications · 2021 · 54 citations · Full text

, , +17

Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens

John C. Kraft, Minh N. Pham, Laila Shehata et al. · Cell Reports Medicine · 2022 · 51 citations · Full text

, , +16

Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses

Victor Yin, Szu‐Hsueh Lai, Tom G. Caniels et al. · ACS Central Science · 2021 · 37 citations · Full text

, , +17

1–5 of 14